Guangdong VTR Bio-Tech Co., Ltd. (SHE:300381)
China · Delayed Price · Currency is CNY 5.27
-0.13 (-2.41%)
Nov 6, 2026, 9:35 AM CST
Guangdong VTR Bio-Tech Balance Sheet
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Cash & Equivalents | 454.21 | 415.75 | 467.01 | 669.16 | 872.58 | 272.7 |
Trading Asset Securities | 10.87 | 198.72 | 332.13 | 563.7 | 688.89 | - |
Cash & Short-Term Investments | 465.08 | 614.47 | 799.13 | 1,233 | 1,561 | 272.7 |
Cash Growth | -31.46% | -23.11% | -35.18% | -21.04% | 472.59% | -10.03% |
Accounts Receivable | 247.51 | 221.76 | 232.18 | 231.91 | 248.79 | 565.34 |
Other Receivables | 8.11 | 5.24 | 3.7 | 8.44 | 5.1 | 26.07 |
Receivables | 255.62 | 227 | 235.89 | 240.35 | 253.89 | 591.41 |
Inventory | 215.55 | 206.55 | 194.71 | 195.72 | 205.37 | 992.45 |
Other Current Assets | 62.54 | 60.4 | 53.75 | 25.62 | 21.81 | 95.38 |
Total Current Assets | 998.8 | 1,108 | 1,283 | 1,695 | 2,043 | 1,952 |
Property, Plant & Equipment | 1,425 | 1,393 | 1,197 | 953.5 | 708.22 | 1,602 |
Long-Term Investments | 3.09 | 3.09 | 2.5 | 9.89 | 10.31 | 20.91 |
Goodwill | 36.67 | 36.67 | 36.67 | 36.67 | 36.67 | 396.06 |
Other Intangible Assets | 300.46 | 341.18 | 365.69 | 363.68 | 338.97 | 422.56 |
Long-Term Deferred Tax Assets | 22.2 | 22.56 | 23.08 | 19.43 | 16.48 | 42.59 |
Long-Term Deferred Charges | 7.38 | 6.29 | 5.78 | 8.18 | 11.16 | 14.99 |
Other Long-Term Assets | 25.89 | 13.29 | 34.22 | 9.03 | 7.79 | 28.74 |
Total Assets | 2,820 | 2,925 | 2,949 | 3,095 | 3,172 | 4,480 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Accounts Payable | 85.13 | 129.98 | 130.12 | 85.67 | 68.95 | 331.62 |
Accrued Expenses | 9.64 | 31.87 | 34.86 | 34.48 | 35.58 | 50.27 |
Short-Term Debt | 50.55 | 62 | 35 | 74.35 | 100 | 656.9 |
Current Portion of Long-Term Debt | 0.12 | - | - | 53.78 | 0.03 | 59.28 |
Current Portion of Leases | - | 0.12 | 0.12 | 0.12 | 0.21 | 0.43 |
Current Income Taxes Payable | 4.7 | 2.1 | 1.6 | 0.86 | 3.8 | 7.04 |
Current Unearned Revenue | 4.62 | 1.99 | 1.8 | 1.91 | 2.3 | 8.08 |
Other Current Liabilities | 36.15 | 51.34 | 39.11 | 57.7 | 37.85 | 53.43 |
Total Current Liabilities | 190.91 | 279.41 | 242.62 | 308.86 | 248.7 | 1,167 |
Long-Term Debt | - | - | - | - | 51.32 | 126.69 |
Long-Term Leases | - | - | - | - | - | 0.24 |
Long-Term Unearned Revenue | 47.14 | 48.08 | 46.9 | 44.44 | 50 | 122.36 |
Long-Term Deferred Tax Liabilities | 3.93 | 4.32 | 4.87 | 5.67 | 6.25 | 15.59 |
Other Long-Term Liabilities | - | - | - | 0.82 | - | - |
Total Liabilities | 241.98 | 331.81 | 294.39 | 359.79 | 356.26 | 1,432 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Common Stock | 480.17 | 491.06 | 491.06 | 490.08 | 490.08 | 490.07 |
Additional Paid-In Capital | 1,552 | 1,636 | 1,633 | 1,618 | 1,614 | 1,610 |
Retained Earnings | 509.49 | 529.78 | 597.57 | 595.18 | 653.73 | 684.51 |
Treasury Stock | - | -100.11 | -100.11 | -100.11 | -61.05 | - |
Comprehensive Income & Other | -10.61 | -7.5 | -9.82 | 11.04 | 8.69 | 8.64 |
Total Common Equity | 2,531 | 2,549 | 2,612 | 2,615 | 2,706 | 2,793 |
Minority Interest | 46.87 | 43.66 | 42.69 | 120.62 | 109.97 | 255.2 |
Shareholders' Equity | 2,578 | 2,593 | 2,654 | 2,735 | 2,816 | 3,048 |
Total Liabilities & Equity | 2,820 | 2,925 | 2,949 | 3,095 | 3,172 | 4,480 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Total Debt | 50.67 | 62.12 | 35.12 | 128.24 | 151.56 | 843.53 |
Net Cash (Debt) | 414.41 | 552.35 | 764.01 | 1,105 | 1,410 | -570.83 |
Net Cash Growth | -28.91% | -27.70% | -30.84% | -21.65% | - | - |
Net Cash Per Share | 0.85 | 1.13 | 1.56 | 2.25 | 2.88 | -1.16 |
Filing Date Shares Outstanding | 487.69 | 480.17 | 480.17 | 479.19 | 483.65 | 490.07 |
Total Common Shares Outstanding | 487.69 | 480.17 | 480.17 | 479.19 | 483.65 | 490.07 |
Working Capital | 807.89 | 829.01 | 1,041 | 1,386 | 1,794 | 784.9 |
Book Value Per Share | 5.19 | 5.31 | 5.44 | 5.46 | 5.59 | 5.70 |
Tangible Book Value | 2,194 | 2,172 | 2,209 | 2,214 | 2,330 | 1,974 |
Tangible Book Value Per Share | 4.50 | 4.52 | 4.60 | 4.62 | 4.82 | 4.03 |
Buildings | - | 1,196 | 949.13 | 686.45 | 683.49 | 1,177 |
Machinery | - | 718.08 | 570.72 | 539.25 | 497.2 | 1,144 |
Construction In Progress | - | 120.54 | 294.12 | 304.27 | 38.47 | 204.74 |